Evidence for including lutein and zeaxanthin in oral supplements for age-related macular degeneration

JAMA Ophthalmology

Volumn 132, Issue 2, 2014, Pages 139-141

  Musch, David C ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; HUMANS; LUTEIN; MALE; WET MACULAR DEGENERATION; XANTHOPHYLLS;

EID: 84894240647     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2013.7443     Document Type: Review

References (17)

1. NIH study provides clarity on supplements for protection against blinding eye disease [press release]. Bethesda, MD: National Eye Institute;May 5, 2013. http://www.nei.nih.gov/news /pressreleases/050513.asp.
2. Age-Related Eye Disease Study 2 (AREDS2) Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial [published correction appears in JAMA. 2013;310(2):208]. JAMA. 2013;309(19):2005-2015.
3. The Age-Related Eye Disease Study 2 (AREDS2) Research Group. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report no. 3 [published online December 5, 2013]. JAMA Ophthalmol. doi:10.1001 /jamaophthalmol.2013.7376.
4. Wittes J. On looking at subgroups. Circulation. 2009;119(7):912-915.
5. Fleming TR,Watelet LF. Approaches to monitoring clinical trials. J Natl Cancer Inst. 1989;81(3):188-193.
6. Dulku S. Subgroup analysis in the Steroids for Corneal Ulcers Trial. Arch Ophthalmol. 2012;130(6):807-808, author reply 808.
7. Srinivasan M, Mascarenhas J, Rajaraman R, et al. Subgroup analysis in the Steroids for Corneal Ulcers Trial: reply. Arch Ophthalmol. 2012;130(6): 807-808.
8. Davis MD, Gangnon RE, Lee LY, et al; Age-Related Eye Disease Study Group. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS report no. 17. Arch Ophthalmol. 2005;123(11):1484-1498.
9. Albanes D, Heinonen OP, Huttunen JK, et al. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am J Clin Nutr. 1995;62(6)(suppl):1427S- 1430S.
10. Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst. 1996;88(21):1550-1559.
11. National Cancer Institute. Lung cancer prevention (PDQ). http://www.cancer.gov /cancertopics/pdq/prevention/lung /HealthProfessional/ page1#Section-206. Accessed October 30, 2013.
12. Guyatt GH, Oxman AD, Vist GE, et al; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650): 924-926.
13. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58(5):295-300.
14. Seddon JM, Ajani UA, Sperduto RD, et al; Eye Disease Case-Control Study Group. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA. 1994;272(18):1413-1420.
15. SanGiovanni JP, Chew EY, Clemons TE, et al; Age-Related Eye Disease Study Research Group. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS report no. 3. Arch Ophthalmol. 2007;125(9):1225-1232
16. Augood C, Chakravarthy U, Young I, et al. Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am J Clin Nutr. 2008;88(2): 398-406.
17. Sangiovanni JP, Agrón E, Meleth AD, et al; Age-Related Eye Disease Study Research Group. omega-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study. Am J Clin Nutr. 2009;90(6):1601-1607.